Luca Di Vito

Showing 1-6 of 6 articles

Coronary interventions

Limitations of OCT in identifying and quantifying lipid components: an in vivo comparison study with IVUS-NIRS

Di Vito L, Imola F, Gatto L, Romagnoli E, Limbruno U, Marco V, Picci A, Micari A, Albertucci M, Prati F

June 20, 2017 | 10.4244/EIJ-D-16-00317

Serial optical coherence tomography imaging of ACS-causing culprit plaques

Souteyrand G, Arbustini E, Motreff P, Gatto L, Di Vito L, Marco V, Amabile N, Chisari A, Kodama T, Romagnoli E, Tavazzi L, Crea F, Narula J, Prati F

July 20, 2015 | 10.4244/EIJV11I3A59

Excimer laser for a highly stenotic saphenous vein graft: evidence of debulking by optical coherence tomography

Niccoli G, Di Vito L, Montone R, Porto I, Crea F

April 22, 2014 | 10.4244/EIJV9I12A249

Stent-related defects in patients presenting with stent thrombosis: differences at optical coherence tomography between subacute and late/very late thrombosis in the Mechanism Of Stent Thrombosis (MOST) study

Parodi G, La Manna A, Di Vito L, Valgimigli M, Fineschi M, Bellandi B, Niccoli G, Giusti B, Valenti R, Cremonesi A, Biondi-Zoccai G, Prati F

December 27, 2013 | 10.4244/EIJV9I8A157

Angiography alone versus angiography plus optical coherence tomography to guide decision-making during percutaneous coronary intervention: the Centro per la Lotta contro l’Infarto-Optimisation of Percutaneous Coronary Intervention (CLI-OPCI) study

Prati F, Di Vito L, Biondi-Zoccai G, Occhipinti M, La Manna A, Tamburino C, Burzotta F, Trani C, Porto I, Ramazzotti V, Imola F, Manzoli A, Materia L, Cremonesi A, Albertucci M

November 20, 2012 | 10.4244/EIJV8I7A125

Coronary artery perforation imaged through 3-dimensional optical coherence tomography

Porto I, Di Vito L, Prati F, Crea F

May 15, 2012 | 10.4244/EIJV8I1A25

1

Latest news

Atherectomies, in-stent restenosis, stent thrombosis, coronary physiology in TAVI and heart failure

Ahead of print: New technique of percutaneous mitral valvuloplasty

C. Aurigemma et al

Rotational atherectomy and the myth of Sisyphus

TICAKOREA, PEPCAD NSTEMI, CROSS-AMI, PARTNER-2A 5 years, and more

(The Trials book is supported by Biotronik)

Guidance Papers

Guidelines, consensus & position papers

Fractional flow reserve substitutes in aortic stenosis

Nils P. Johnson

This Week's JAA's: Real-world Use of the Evolut PRO Valve...

Valvular disease